Related Experiment Video
Updated: Aug 13, 2026
06:08
Transcranial Pulse Stimulation for Alzheimer's Patients
Published on: April 4, 2025
Alzheimer's disease: stage-related interventions
1Aging and Dementia Research Center, Department of Psychiatry, New York University Medical Center, NY, USA.
Lippincott'S Case Management : Managing the Process of Patient Care
|January 10, 2006
Summary
Alzheimer's Disease (AD) is the most common dementia in older adults, causing progressive cognitive decline and caregiving burdens. Understanding AD's stages helps case managers connect patients with vital community resources.
Area of Science:
- Gerontology
- Neurology
- Public Health
Background:
- Alzheimer's Disease (AD) is the leading cause of dementia in individuals over 60.
- AD progresses from initial forgetfulness to severe cognitive deficits and loss of adaptive capabilities.
- Advanced AD necessitates total patient care, imposing significant strains on resources.
Purpose of the Study:
- To outline the progressive clinical symptomatology of Alzheimer's Disease.
- To assist case managers in linking patient needs with community resources.
- To improve care coordination for elderly individuals with AD.
Main Methods:
- Literature review of Alzheimer's Disease progression.
- Analysis of caregiving burdens and resource utilization.
- Framework development for case management in AD.
Main Results:
- Detailed description of AD's evolving clinical presentation.
- Identification of factors contributing to caregiving strain.
- Emphasis on the role of case managers in service coordination.
Conclusions:
- Accurate understanding of AD progression is crucial for effective case management.
- Case managers play a vital role in navigating fragmented healthcare and support services.
- Improved resource linkage can alleviate patient and caregiver burdens.
Related Concept Videos
01:22Alzheimer's Disease: Treatment
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
01:26Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
01:30Dementia
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual.
The progression of dementia is generally gradual.
01:22Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...